Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Alnylam Pharmaceuticals
Sander F Garrelfs; Yaacov Frishberg; Sally A Hulton; Michael J Koren; William D O'Riordan; Pierre Cochat; Georges Deschênes; Hadas Shasha-Lavsky; Jeffrey M Saland; William G Van't Hoff; Daniel G Fuster; Daniella Magen; Shabbir H Moochhala; Gesa Schalk; Eva Simkova; Jaap W Groothoff; David J Sas; Kristin A Meliambro; Jiandong Lu; Marianne T Sweetser; Pushkal P Garg; Akshay K Vaishnaw; John M Gansner; Tracy L McGregor; John C Lieske; ILLUMINATE-A Collaborators